摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-nitro-1-phenylpyrazole-3-carbonitrile | 1426541-58-3

中文名称
——
中文别名
——
英文名称
4-nitro-1-phenylpyrazole-3-carbonitrile
英文别名
4-nitro-1-phenyl-1H-pyrazole-3-carbonitrile;4-Nitro-1-phenylpyrazole-3-carbonitrile
4-nitro-1-phenylpyrazole-3-carbonitrile化学式
CAS
1426541-58-3
化学式
C10H6N4O2
mdl
——
分子量
214.183
InChiKey
FAPZQSKQUGPCSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    424.1±30.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    87.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-nitro-1-phenylpyrazole-3-carbonitrile4-二甲氨基吡啶 、 1-hydroxybenzotriazole hydrochloride 、 palladium 10% on activated carbon 、 ammonium acetate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺环己烯 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 168.58h, 生成 N-(5-methyl-2-phenylpyrazolo[4,3-d]pyrimidin-7-yl)-2-phenylacetamide
    参考文献:
    名称:
    2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3 Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation
    摘要:
    On the basis of our previously reported 2-arylpyrazolo[4,3-d]pyrimidin-7-ones, a set of 2-arylpyrazolo[4,3- d]pyrimidin-7-amines were designed as new human (h) A(3) adenosine receptor (AR) antagonists. Lipophilic groups with different steric bulk were introduced at the 5-position of the bicyclic scaffold (R-5 = Me, Ph, CH2Ph), and different acyl and carbamoyl moieties (R-7) were appended on the 7-amino group, as well as a para-methoxy group inserted on the 2-phenyl ring. The presence of acyl groups turned out to be of paramount importance for an efficient and selective binding at the hA(3) AR In fact, most of the 7-acylamino derivatives showed low nanomolar affinity (K-l, = 2.5-45 nM) and high selectivity toward this receptor. A few selected pyrazolo[4,3-d]pyrimidin-7-amides were effective in counteracting oxaliplatin-induced apoptosis in rat astrocyte cell cultures, an in vitro model of neurotoxicity. Through an in silica receptor-driven approach the obtained binding data were rationalized and the molecular bases of the observed hA(3) AR affinity and hA(3) versus hA(2A) AR selectivity were explained.
    DOI:
    10.1021/jm400068e
  • 作为产物:
    描述:
    参考文献:
    名称:
    探索吡唑并[4,3-d]嘧啶-7-氨基支架的2位和5位靶向人A1和A2A腺苷受体。
    摘要:
    合成了一系列新的7-氨基吡唑并[4,3-d]嘧啶衍生物(1-31),以评估2位和5位的一些结构修饰,旨在改变对人(h)A2A腺苷受体( AR)或hA2A和hA1 ARs。活性最高的化合物是那些在位置5处带有2-呋喃基或5-甲基呋喃-2-基的化合物,在位置2处带有苄基或取代的苄基,其中一些衍生物(22-31)具有纳摩尔浓度对hA2A AR的亲和力(Ki = 3.62-57nM),对hA1 AR的亲和力略低,因此显示出相对于hA1选择性而言,hA2A的程度不同(3-22倍)。尤其是,2-(2-甲氧基苄基)-5-(5-甲基呋喃-2-基)衍生物25具有最高的hA2A和hA1 AR亲和力(Ki = 3.62nM和18nM,并在这两个受体上均表现出强大的拮抗作用(cAMP分析)。它的2-(2-羟基苄基)类似物26对hA2A AR也有很高的亲和力(Ki = 5.26nM),相对于hA1亚型具有22倍的选择性。在hA2A
    DOI:
    10.1016/j.bmc.2016.04.048
点击查看最新优质反应信息

文献信息

  • The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-<i>d</i>]pyrimidine core in affecting adenosine A<sub>1</sub> and A<sub>2A</sub> receptor affinity and selectivity profiles
    作者:Lucia Squarcialupi、Marco Betti、Daniela Catarzi、Flavia Varano、Matteo Falsini、Annalisa Ravani、Silvia Pasquini、Fabrizio Vincenzi、Veronica Salmaso、Mattia Sturlese、Katia Varani、Stefano Moro、Vittoria Colotta
    DOI:10.1080/14756366.2016.1247060
    日期:2017.1.1
    New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A1 and/or A2A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA2B and hA3 ARs. The 5-(4-hydroxyphenethylamino)- derivative
    合成了新的7-氨基-2-苯基吡唑并[4,3-d]嘧啶衍生物,该衍生物在5-位被芳基(烷基)氨基和4-取代的哌嗪-1-基部分取代,目的是:靶向人(h)腺苷A1和/或A2A受体亚型。总体而言,新的衍生物1-24对脱靶hA2B和hA3 ARs缺乏亲和力或没有亲和力。5-(4-羟基苯乙氨基)-衍生物12对hA2A AR表现出良好的亲和力(Ki = 150 nM)和最佳选择性,而5-苄基氨基取代的5显示出最佳的hA2A(Ki = 123 nM)和A1组合AR亲和力(Ki = 25 nM)。5-苯乙基氨基部分(化合物6)实现了纳摩尔亲和力(Ki = 11 nM)和对hA1 AR的良好选择性。5-(N4-取代的哌嗪-1-基)衍生物15-24以高纳摩尔范围内的亲和力结合hA1 AR亚型。
  • Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors
    作者:Lucia Squarcialupi、Matteo Falsini、Daniela Catarzi、Flavia Varano、Marco Betti、Katia Varani、Fabrizio Vincenzi、Diego Dal Ben、Catia Lambertucci、Rosaria Volpini、Vittoria Colotta
    DOI:10.1016/j.bmc.2016.04.048
    日期:2016.6
    receptors (cAMP assays). Its 2-(2-hydroxybenzyl) analog 26 also showed a high affinity for the hA2A AR (Ki=5.26nM) and was 22-fold selective versus the hA1 subtype. Molecular docking investigations performed at the hA2A AR crystal structure and at a homology model of the hA1 AR allowed us to represent the hypothetical binding mode of our derivatives and to rationalize the observed SARs.
    合成了一系列新的7-氨基吡唑并[4,3-d]嘧啶衍生物(1-31),以评估2位和5位的一些结构修饰,旨在改变对人(h)A2A腺苷受体( AR)或hA2A和hA1 ARs。活性最高的化合物是那些在位置5处带有2-呋喃基或5-甲基呋喃-2-基的化合物,在位置2处带有苄基或取代的苄基,其中一些衍生物(22-31)具有纳摩尔浓度对hA2A AR的亲和力(Ki = 3.62-57nM),对hA1 AR的亲和力略低,因此显示出相对于hA1选择性而言,hA2A的程度不同(3-22倍)。尤其是,2-(2-甲氧基苄基)-5-(5-甲基呋喃-2-基)衍生物25具有最高的hA2A和hA1 AR亲和力(Ki = 3.62nM和18nM,并在这两个受体上均表现出强大的拮抗作用(cAMP分析)。它的2-(2-羟基苄基)类似物26对hA2A AR也有很高的亲和力(Ki = 5.26nM),相对于hA1亚型具有22倍的选择性。在hA2A
  • 2-Arylpyrazolo[4,3-<i>d</i>]pyrimidin-7-amino Derivatives As New Potent and Selective Human A<sub>3</sub> Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation
    作者:Lucia Squarcialupi、Vittoria Colotta、Daniela Catarzi、Flavia Varano、Guido Filacchioni、Katia Varani、Carmen Corciulo、Fabrizio Vincenzi、Pier Andrea Borea、Carla Ghelardini、Lorenzo Di Cesare Mannelli、Antonella Ciancetta、Stefano Moro
    DOI:10.1021/jm400068e
    日期:2013.3.28
    On the basis of our previously reported 2-arylpyrazolo[4,3-d]pyrimidin-7-ones, a set of 2-arylpyrazolo[4,3- d]pyrimidin-7-amines were designed as new human (h) A(3) adenosine receptor (AR) antagonists. Lipophilic groups with different steric bulk were introduced at the 5-position of the bicyclic scaffold (R-5 = Me, Ph, CH2Ph), and different acyl and carbamoyl moieties (R-7) were appended on the 7-amino group, as well as a para-methoxy group inserted on the 2-phenyl ring. The presence of acyl groups turned out to be of paramount importance for an efficient and selective binding at the hA(3) AR In fact, most of the 7-acylamino derivatives showed low nanomolar affinity (K-l, = 2.5-45 nM) and high selectivity toward this receptor. A few selected pyrazolo[4,3-d]pyrimidin-7-amides were effective in counteracting oxaliplatin-induced apoptosis in rat astrocyte cell cultures, an in vitro model of neurotoxicity. Through an in silica receptor-driven approach the obtained binding data were rationalized and the molecular bases of the observed hA(3) AR affinity and hA(3) versus hA(2A) AR selectivity were explained.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺